Cargando…
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
The presence of blood–brain barrier (BBB) and/or blood–brain–tumor barriers (BBTB) is one of the main obstacles to effectively deliver therapeutics to our central nervous system (CNS); hence, the outcomes following treatment of malignant brain tumors remain unsatisfactory. Although some approaches r...
Autores principales: | Wu, Sheng-Kai, Tsai, Chia-Lin, Huang, Yuexi, Hynynen, Kullervo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823947/ https://www.ncbi.nlm.nih.gov/pubmed/33374205 http://dx.doi.org/10.3390/pharmaceutics13010015 |
Ejemplares similares
-
Microbubble drug conjugate and focused ultrasound blood brain barrier delivery of AAV-2 SIRT-3
por: Trinh, Dennison, et al.
Publicado: (2022) -
Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments
por: Poon, Charissa, et al.
Publicado: (2021) -
Neutrophil Recruitment and Leukocyte Response Following Focused Ultrasound and Microbubble Mediated Blood-Brain Barrier Treatments
por: Poon, Charissa, et al.
Publicado: (2022) -
Microbubble formulation influences inflammatory response to focused ultrasound exposure in the brain
por: McMahon, Dallan, et al.
Publicado: (2020) -
Reply to Kovacs et al.: Concerning acute inflammatory response following focused ultrasound and microbubbles in the brain
por: McMahon, Dallan, et al.
Publicado: (2018)